by Vanderbilt University Medical Center Credit: Pixabay/CC0 Public Domain GLP1 receptor agonists—a class of diabetes medications—are associated with fewer major adverse cardiovascular events than another type of diabetes drug (DPP4 inhibitors) in older veterans with no prior heart disease. The findings, reported in Annals of Internal Medicine, will aid clinicians in choosing a diabetes drug regimen for older...
by Erin Howe, University of Toronto Credit: CC0 Public Domain A class of medication for type 2 diabetes may help older people with the condition reduce their risk of dementia. The findings are contained in a new study by Walter Swardfager, an assistant professor of pharmacology and toxicology at the Temerty Faculty of Medicine and...
by British Medical Journal Picture of the back of the eye showing intermediate age-related macular degeneration. Credit: National Eye Institute Regular use of drugs to lower cholesterol and control type 2 diabetes may lessen the risk of the degenerative eye disease associated with aging, known as AMD, finds a pooled data analysis of the available...
by National Institute of Diabetes and Digestive and Kidney Diseases Credit: Pixabay/CC0 Public Domain In a large clinical trial that directly compared four drugs commonly used to treat type 2 diabetes, researchers found that insulin glargine and liraglutide performed the best of four medications approved by the U.S. Food and Drug Administration to maintain blood...
by American Society of Nephrology Graphical abstract: Journal of the American Society of Nephrology (2022). DOI: 10.2215/CJN.16171221 Sodium glucose transport-2 (SGLT-2) inhibitors, which reduce glucose reabsorption by the kidneys, can help control blood sugar levels and protect kidney health in patients with diabetic kidney disease; however, some large clinical trials have linked the medications to a higher...
New research has linked two types of less-often prescribed diabetes drugs with lower chances of potentially fatal heart problems – including heart attack, heart failure and stroke – in people with type 2 diabetes without established heart disease. The study of English and Welsh data – led by University of Manchester and Manchester University NHS Foundation Trust (MFT) scientists, is published...
New research has linked two types of less-often prescribed diabetes drugs with lower chances of potentially fatal heart problems – including heart attack, heart failure and stroke – in people with type 2 diabetes without established heart disease. The study of English and Welsh data – led by University of Manchester and Manchester University NHS Foundation Trust (MFT) scientists, is published...
Pauline Anderson August 11, 2021 Among patients with cognitive impairment, those with diabetes who took dipeptidyl peptidase-4 (DPP-4) inhibitors had less amyloid-beta (Aβ) in the brain compared to the patients with diabetes who did not take these medications and to the patients without diabetes, new research shows. DPP-4 inhibitors are a class of oral hypoglycemic agents. The...
by American Academy of Neurology Diagram of the brain of a person with Alzheimer’s Disease. Credit: Wikipedia/public domain. People taking certain drugs to lower blood sugar for type 2 diabetes had less amyloid in the brain, a biomarker of Alzheimer’s disease, when compared to both people with type 2 diabetes not taking the drugs and people...
by Johns Hopkins University School of Medicine Credit: Unsplash/CC0 Public Domain New medicines for people who have diabetes seem to pop up all the time. Drugs that help the body break down carbohydrates, drugs that increase excretion of glucose in the urine, drugs that help muscles respond to insulin and drugs that stimulate the pancreas to...
